Navigation Links
Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs
Date:3/1/2010

SARASOTA, Florida, March 1, 2010 /PRNewswire/ -- Citius Tech, a leading provider of healthcare technology solutions and services, announced today the launch of BI-Clinical MUSE - an enhanced version of its healthcare business intelligence framework - BI-Clinical - for "Meaningful Use" Analytics & Reporting compliance.

The BI-Clinical framework provides an integrated approach for clinical, operational, financial and regulatory performance management in healthcare for hospitals, physician practices and managed care organizations - covering over 600 measures. BI-Clinical hospital module includes acute care reporting (e.g., AMI, pneumonia and stroke) and measures for CMS, JCAHO, P4P, and NCQA. Similarly, BI-Clinical physician practice module includes registry-based reporting for chronic diseases such as diabetes, hypertension, COPD, CAD as well as measures for PQRI and DOQ-IT.

The recent "meaningful use" requirements published by HHS mandate clinical quality reporting measures for hospitals and physician practices. Citius Tech has customized the BI-Clinical framework for "meaningful use" - BI-Clinical MUSE - to cover all reporting requirements for hospitals (443 measures in 2011) and physician practices (90 measures in 2011). BI-Clinical MUSE also supports public health data submission.

"The meaningful use guidelines impose significant technology & reporting requirements for healthcare ISVs and care providers" said Bimal R. Naik, Senior Vice President at Citius Tech. "BI-Clinical MUSE is designed as a modular framework which can be bundled with EHRs and other clinical applications. Microsoft's Business Intelligence stack provides a highly flexible and scalable deployment platform for BI-Clinical."

"Hospitals and health organizations are faced with an abundance of quality measures that they must report on," said Chris Sullivan, U.S. health provider industry solutions director, Microsoft. "Citius Tech's BI-Clinical framework, based on the Microsoft Business Intelligence platform, helps healthcare organizations with this quality measures reporting."

About Citius Tech

Citius Tech (http://www.citiustech.com ) is a specialist provider of technology solutions and services to healthcare technology companies, providers, MCOs, and health plans. Citius Tech practice areas include healthcare software engineering, healthcare interoperability, healthcare business intelligence and CRMM. Citius Tech brings strong healthcare domain expertise - across technologies, applications and standards. Thee ability to provide this expertise, together with world-class service quality and a global resource base , enables Citius Tech to offer a distinctive value proposition to our clients.

    Product and company names herein may be the trademarks of their
respective owners.

    Citius Tech Inc.
    Amar Badlani
    amarb@cittiustech.com
    Off: +1-36-0-326-8060

SOURCE Citius Tech Inc

Back to top
'/>"/>
SOURCE Citius Tech Inc
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Novozymes Launches Enzyme to Reduce Acrylamide in Food
4. Enova Medical Launches Exos Corporation
5. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
6. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
7. ThirdBiotech Networking Group Launches
8. BioReliance Launches Next-Generation Genotoxicity Screening Service
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. BioReliance Corporation Launches iNet(TM) for Online Results Tracking of Biological Safety Tests
11. Kingfisher Healthcare Launches Breakthrough Product in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):